Mobile

The trial is designed to determine the long-term safety and efficacy of ABP 501 in subjects with moderate to severe rheumatoid arthritis

Update Il y a 4 ans
Reference: EUCTR2013-004654-13

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to evaluate the long-term safety and efficacy of ABP 501 in subjects with moderate to severe rheumatoid arthritis.

Inclusion criteria

  • Moderate to Severe Rheumatoid Arthritis

Links